We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-2.53%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$44.3B
AUM Growth
+$548M
(+1.3%)
Cap. Flow
+$2.58B
Cap. Flow
% of AUM
5.82%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
2,291
New
20
Increased
497
Reduced
1,558
Closed
209
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$224M |
| 2 |
Microsoft
MSFT
|
+$200M |
| 3 |
Eversource Energy
ES
|
+$180M |
| 4 |
Erie Indemnity
ERIE
|
+$178M |
| 5 |
Amazon
AMZN
|
+$173M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$51.8M |
| 2 |
Cardinal Health
CAH
|
+$45.2M |
| 3 |
Williams-Sonoma
WSM
|
+$44.3M |
| 4 |
Walmart Inc
WMT
|
+$43.9M |
| 5 |
IBM
IBM
|
+$35.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.93% |
| 2 | Consumer Staples | 10.3% |
| 3 | Consumer Discretionary | 10.1% |
| 4 | Financials | 9.92% |
| 5 | Industrials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
The RealReal
REAL
$1.34B
| $118K | ﹤0.01% |
21,935
-6,262
| -22% | -$47.5K |
|
|
XRN
1802
Chiron Real Estate Inc
XRN
$544M
| $117K | ﹤0.01% |
2,679
-743
| -22% | -$30.7K |
|
|
SAGE
1803
DELISTED
Sage Therapeutics
SAGE
| $116K | ﹤0.01% |
14,597
-3,684
| -20% | -$27K |
|
|
GTM
1804
ZoomInfo Technologies
GTM
$861M
| $116K | ﹤0.01% |
11,557
-1,134
| -9% | -$11.9K |
|
1805
Accel Entertainment
ACEL
$979M
| $115K | ﹤0.01% |
11,612
-2,938
| -20% | -$32K |
|
1806
Opko Health
OPK
$921M
| $115K | ﹤0.01% |
69,045
-22,685
| -25% | -$37.4K |
|
|
LGF.A
1807
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $114K | ﹤0.01% |
12,895
-3,880
| -23% | -$34.9K |
|
1808
Hertz
HTZ
$572M
| $114K | ﹤0.01% |
28,898
-8,086
| -22% | -$32.5K |
|
1809
UroGen Pharma
URGN
$2B
| $114K | ﹤0.01% |
10,279
-2,616
| -20% | -$27.9K |
|
|
DHC
1810
Diversified Healthcare Trust
DHC
$2.26B
| $113K | ﹤0.01% |
47,283
-14,233
| -23% | -$35.1K |
|
|
ACCD
1811
DELISTED
Accolade Inc
ACCD
| $113K | ﹤0.01% |
16,144
-4,430
| -22% | -$29.7K |
|
|
BORR
1812
Borr Drilling
BORR
$1.31B
| $112K | ﹤0.01% |
51,321
-15,444
| -23% | -$46.5K |
|
|
DFTX
1813
Definium Therapeutics
DFTX
$5.73B
| $112K | ﹤0.01% |
19,209
-6,958
| -27% | -$49.8K |
|
1814
Cytek Biosciences
CTKB
$576M
| $111K | ﹤0.01% |
27,767
-8,474
| -23% | -$43.9K |
|
|
MTAL
1815
DELISTED
Metals Acquisition
MTAL
| $111K | ﹤0.01% |
11,660
-3,510
| -23% | -$37.1K |
|
|
DCH
1816
Dauch Corp
DCH
$1.3B
| $110K | ﹤0.01% |
27,123
-7,577
| -22% | -$38.9K |
|
1817
RPC Inc
RES
$1.24B
| $110K | ﹤0.01% |
20,000
-5,563
| -22% | -$33.1K |
|
1818
JELD-WEN Holding
JELD
$94.8M
| $109K | ﹤0.01% |
18,286
-5,504
| -23% | -$40.9K |
|
1819
Nordic American Tanker
NAT
$1.37B
| $109K | ﹤0.01% |
44,128
-13,280
| -23% | -$35K |
|
1820
Maravai LifeSciences
MRVI
$997M
| $106K | ﹤0.01% |
47,974
-7,514
| -14% | -$29.7K |
|
|
NPKI
1821
NPK International
NPKI
$1.21B
| $106K | ﹤0.01% |
18,201
-5,480
| -23% | -$36.4K |
|
1822
Cullinan Oncology
CGEM
$1.05B
| $106K | ﹤0.01% |
13,953
-3,373
| -19% | -$32.4K |
|
|
TRTX
1823
TPG RE Finance Trust
TRTX
$666M
| $105K | ﹤0.01% |
12,911
-3,886
| -23% | -$32.9K |
|
1824
Ivanhoe Electric
IE
$1.43B
| $105K | ﹤0.01% |
18,095
-5,446
| -23% | -$34.5K |
|
1825
Zevra Therapeutics
ZVRA
$563M
| $105K | ﹤0.01% |
14,022
-3,403
| -20% | -$27K |
|
Similar funds
ProShare Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, ProShare Advisors held 2,291 positions worth $44.3B, up 1.3% from $43.8B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors deployed $2.58B of net new capital in Q1 2025, opening 20 new positions and adding to 497 existing holdings. Its largest new stake was ManpowerGroup: 504,581 shares worth $29.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Emerson Electric, an estimated $51.8M trimmed.
- ProShare Advisors's largest Q1 2025 buy was ManpowerGroup: 504,581 shares worth $29.2M.
- ProShare Advisors added most to Apple in Q1 2025, an estimated $224M increase.
- ProShare Advisors's biggest Q1 2025 reduction was Emerson Electric, cutting an estimated $51.8M.
- ProShare Advisors fully exited Premier Financial Corp. Common Stock in Q1 2025, selling an estimated $7.12M.
- ProShare Advisors's ten largest holdings make up 27% of its $44.3B portfolio in Q1 2025.
- ProShare Advisors opened 20 new positions and closed 209 in Q1 2025.
- ProShare Advisors's portfolio value rose 1.3% quarter-over-quarter to $44.3B.
Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.